Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Urology|November 3, 2012
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programmeAxel Heidenreich, Hans-Jörg Scholz, Sebastian Rogenhofer, et al.
International Journal of Cancer|September 19, 2022
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trialAgne Krilaviciute, Peter Albers, Jale Lakes, et al.
European Urology|July 13, 2026
Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE TrialAgne Krilaviciute, Nikolaus Becker, Sigrid V Carlsson, et al.
Journal of Behavioral Medicine|March 5, 2025
Worry about prostate cancer and risk perception among middle-aged men: results from the PROBASE trialValentin H Meissner, Andreas Dinkel, Martina Kron, et al.
European Urology Oncology|July 10, 2025
Do We Need Early Detection of Grade Group 2 Prostate Cancer in a Screening Program for Young Men? Results from the PROBASE Screening TrialPeter Albers, Agne Krilaviciute, Petra Seibold, et al.
European Urology|May 15, 2024
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE TrialAgne Krilaviciute, Rudolf Kaaks, Petra Seibold, et al.
European Urology Oncology|October 8, 2023
Digital Rectal Examination Is Not a Useful Screening Test for Prostate CancerAgne Krilaviciute, Nikolaus Becker, Jale Lakes, et al.
European Urology|June 3, 2025
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE TrialRouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
European Urology|October 20, 2023
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE TrialMatthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al.
European Urology Oncology|June 1, 2026
MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE TrialMatthias Boschheidgen, Rouvier Al-Monajjed, Heinz-Peter Schlemmer, et al.
Pageof 6